Paradigm Biocapital Advisors LP
- SEC CIK
- 0001855655
- Latest filing
- Aug 14, 2026
PSTX holding history
Poseida Therapeutics, Inc. in every 13F filed by Paradigm Biocapital Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PSTX overviewAll 13F holders of PSTXFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −1,072,410−100.0% | Sold out | Holders |
| Q1 2023 | 1,072,410 | $3.30M | 0.3% | −1,362,406−56.0% | Reduced | Holders |
| Q4 2022 | 2,434,816 | $12.9M | 1.5% | +364,708+17.6% | Added | Holders |
| Q3 2022 | 2,070,108 | $7.31M | 1.0% | +2,070,108 | New | Holders |